personalisation

Digital

Designing personalised digital experiences that engage healt...

Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they use in their daily lives.

Sales & Marketing

Evolving HCP access requires a new connected approach to bui...

Specialty medicines – treatments designed for very small patient populations with complex and rare conditions – are on the rise.

Sales & Marketing

How to harmonise global content strategies with local needs ...

Any pharma business operating on a global scale would naturally strive to execute a uniformed content marketing strategy across all markets.

Digital

Conceptualisation of AI brain and circuit board

Going beyond the hype: Embracing AI for strategic advantage

The transformative potential of artificial intelligence (AI) within medical affairs has been widely discussed, yet, realising its real-world commercial value requires a pragmatic approach t

R&D

Generative AI in clinical trials: Practical use cases and co...

With the hype around generative AI (GenAI), there is an increasing demand to explore its capabilities across pharma and MedTech companies, as well as contract research organisations.

Oncology

Henar Hevia and Carolyn Sousa at ASCO 2024

ASCO 2024 - Henar Hevia and Carolyn Sousa

The future of cancer care is personalisation. New breakthroughs are increasingly highly targeted, with powerful results, but only for patients with particular genetic markers.